PAR paradigm biopharmaceuticals limited..

Paul has alluded to a partnership subject to fda approval for...

  1. 508 Posts.
    lightbulb Created with Sketch. 63
    Paul has alluded to a partnership subject to fda approval for p3.....FDa approval has now been granted..so he needs to walk the talk now....He claims there is some parties interested. He and Matt are travelling to the USA in january for discussions.....What are our chances of a deal being struck first quarter 2025 ? how might that affect the sp ?????
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
28.0¢
Change
0.000(0.00%)
Mkt cap ! $115.3M
Open High Low Value Volume
28.5¢ 29.0¢ 27.5¢ $266.0K 933.1K

Buyers (Bids)

No. Vol. Price($)
2 30648 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 20000 1
View Market Depth
Last trade - 16.10pm 18/09/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.